The case: In Royal Canin India Pvt. Ltd. (ITA No. 8837/MUM/2025, AY 2022-23, decided 20 May 2026), the TPO set the arm's length price of a franchise fee paid to the foreign parent at nil.
The ruling: The Tribunal deleted the adjustment. The fee paid for distinct rights (trademarks, know-how and support services), not for product costs already covered elsewhere. The TPO cannot apply a "need-benefit" test or question commercial expediency.
The ruling adds to a long line of cases rejecting nil ALPs that rest on the TPO's view of benefit rather than a prescribed method.

